Abstracts

INCREASED GUT PERMEABILITY AND OXIDIZED LIPIDS IN PASC

Background: Post-acute sequelae of COVID-19 (PASC) is marked by persistent or newly developing symptoms beyond 4 weeks of infection. Investigating gut integrity, oxidized lipids and inflammatory markers is important for understanding PASC pathogenesis. Methods: A cross-sectional study including COVID+ with PASC, COVID+ without PASC, and COVID- participants. We measured plasma markers by enzyme-linked immunosorbent assay…

HOSPITAL PROTECTION CORRELATES IN OUTPATIENT COVID-19 CONVALESCENT PLASMA RECIPIENTS

Background: High titer COVID-19 convalescent plasma (CCP) reduces hospitalizations among immunocompetent outpatients. This study evaluated recipient post-transfusion S receptor binding domain (S-RBD) IgG antibody levels and the association of progressing to hospitalization among unvaccinated outpatients with COVID-19 treated with CCP or control plasma. Methods: This analysis focused on participants from a multicenter double-blind, randomized, controlled…

ACHIEVING THE EHE INCIDENCE REDUCTION GOALS AMONG AT-RISK POPULATIONS IN THE SOUTH

Background: Antiretroviral therapy (ART) coverage remains sub-optimal in much of the United States, particularly the Sothern region, and Non-Hispanic Black or African American persons (NHB) continue to be disproportionately impacted by the HIV epidemic. The “Ending the HIV Epidemic in the U.S.” (EHE) initiative seeks to reduce HIV incidence nationally by focusing resources towards the…

A JOINT ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS ON ENOXAPARIN FOR COVID-19

Background: COVID-19 carries a high risk of vascular thrombosis. This joint analysis of two randomized-controlled trials (RCTs) aims to assess the safety and efficacy of enoxaparin at therapeutic dose compared to prophylactic dose in people hospitalized with COVID-19. Methods: A joint analysis of two RCTs, COVID-19 HD (NCT044082359) and EMOS-COVID (NCT04646655), was performed. Both studies…

EQUITY-BASED OPTIMIZATION FOR COVID-19 VACCINE ALLOCATION

Background: Despite the development of safe and effective vaccines and antiviral treatments against COVID- 19, marginalized racial/ethnic groups in the United States continue to be disproportionally burdened by COVID-19. In response to this inequity, public health officials in several states designed, usually in an ad-hoc manner, policies aimed to be more equitable in both access…

SARS-CoV-2 SEROPREVALENCE AMONG PEOPLE WHO INJECT DRUGS IN BALTIMORE

Background: People who inject drugs (PWID) may be at a greater risk of SARS-CoV-2 infection and COVID-19 due to socio-structural inequities, high-risk behaviors and comorbidities; however, PWID have been underrepresented in case-based surveillance due to lower access to testing. We characterize temporal trends and correlates of SARS-CoV-2 seroprevalence among a community-based sample of current and…